Skip to main content

Galectin Therapeutics Inc

GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001133416

In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 3 sales; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.9M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Galectin Therapeutics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
2 insiders, $496.3K in total
Insiders trading
2
Net value
−$496.3K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Galectin Therapeutics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Galectin Therapeutics Inc
NameTitleLast reported holdingLast filingFilings, past year
Uihlein Richard EDirector, 10% Owner44,713,843IndirectAug 4, 20262
Jamil KhurramChief Medical Officer0Jul 16, 20269
Shlevin Harold H.Director6,500Jun 30, 20265
Brem HenryDirector–Mar 17, 20261
Eldred KaryDirector65,682Feb 9, 20264
Lewis JoelPresident and CEO776,260Jan 22, 20268
Carson Benjamin SrDirector–Jan 21, 20261
Amelio Gilbert FDirector–Jan 21, 20261
Omenn Gilbert SDirector–Jan 21, 20261
Callicutt Jack WChief Financial Officer7,614Jan 21, 20266
Freeman Kevin DDirector55,269Jan 21, 20262
Schwartz Elissa J.Director1,000Jan 21, 20261
Zordani Richard A. Jr.Director42,083Jan 21, 20261
Czirr James C10% Owner5,614,457Dec 18, 20254
10X Fund, L.P.10% Owner5,614,457Dec 18, 20254
10X Capital Management, LLC10% Owner5,614,457Dec 18, 20254
Rubin MarcDirector–Jan 27, 20250
Boudes Pol FChief Medical Officer–Feb 7, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 16, 2026 (view filing)5:39 PM ETJul 142 daysJamil KhurramChief Medical OfficerSSale−16.3K$5.13−$83.3K−100.0%0 after10b5-1
Jun 30, 2026 (view filing)Jun 26-294 daysShlevin Harold H.DirectorSSale−30.0K$5.03−$150.9K−82.2%6.50K after2 lots10b5-1
Jun 30, 2026 (view filing)Jun 26-294 daysJamil KhurramChief Medical OfficerSSale−52.0K$5.04−$262.1K−100.0%0 after3 lots10b5-1
Jun 25, 2026 (view filing)Jun 232 daysJamil KhurramChief Medical OfficerSSale−7.56K$3.14−$23.7K−100.0%0 after10b5-1
May 28, 2026 (view filing)May 262 daysJamil KhurramChief Medical OfficerSSale−568$3.10−$1.76K−100.0%0 after10b5-1
Feb 9, 2026 (view filing)Feb 63 daysEldred KaryDirectorPPurchase+300$2.70+$810+0.5%65.7K after
Jan 6, 2026 (view filing)Jan 2-64 daysLewis JoelPresident and CEOSSale−84.0K$3.83−$321.4K−9.2%832.6K after3 lots10b5-1
Jan 6, 2026 (view filing)Jan 2-64 daysCallicutt Jack WChief Financial OfficerSSale−60.0K$3.89−$233.5K−88.7%7.61K after3 lots10b5-1
Jan 6, 2026 (view filing)Jan 2-64 daysJamil KhurramChief Medical OfficerSSale−34.5K$3.86−$133.1K−100.0%0 after2 lots10b5-1
Jan 6, 2026 (view filing)Jan 51 dayJamil KhurramChief Medical OfficerSSale−25.5K$3.90−$99.4K−54.3%21.4K after10b5-1
Jan 5, 2026 (view filing)Dec 31, 20255 daysJamil KhurramChief Medical OfficerSSale−8.13K$4.07−$33.1K−100.0%0 after10b5-1
Dec 23, 2025 (view filing)Dec 23Same dayFreeman Kevin DDirectorPPurchase+5.50K$3.55+$19.5K+11.1%55.3K afterAmended
Dec 23, 2025 (view filing)Dec 23Same dayEldred KaryDirectorPPurchase+700$3.73+$2.61K+1.1%65.4K afterDuplicate filing
Dec 23, 2025 (view filing)Dec 23Same dayEldred KaryDirectorPPurchase+700$3.73+$2.61K+1.1%65.4K after10b5-1
Dec 19, 2025 (view filing)Dec 172 daysLewis JoelPresident and CEOSSale−7.83K$7.06−$55.3K−0.9%832.6K after10b5-1
Dec 19, 2025 (view filing)Dec 172 daysJamil KhurramChief Medical OfficerSSale−19.4K$7.04−$136.9K−100.0%0 after3 lots10b5-1
Dec 19, 2025 (view filing)Dec 172 daysShlevin Harold H.DirectorSSale−24.5K$7.04−$172.5K−79.0%6.50K after2 lots10b5-1
Dec 18, 2025 (view filing)10:34 AM ETDec 162 daysCzirr James C and 2 others10% OwnerSSale−30.7K$6.66−$204.3K−0.5%5.61M after
Dec 16, 2025 (view filing)Dec 12-154 daysShlevin Harold H.DirectorSSale−28.2K$6.28−$177.1K−71.6%11.2K after2 lots10b5-1
Dec 10, 2025 (view filing)Dec 8-92 daysShlevin Harold H.DirectorSSale−155.8K$6.01−$936.2K−93.3%11.2K after7 lots10b5-1
Dec 10, 2025 (view filing)Dec 82 daysShlevin Harold H.DirectorSSale−20.0K$5.96−$119.2K−64.1%11.2K after10b5-1
Dec 8, 2025 (view filing)1:21 PM ETDec 2-36 daysCzirr James C and 2 others10% OwnerSSale−162.1K$5.68−$920.9K−2.8%5.67M afterAmended2 lots
Nov 19, 2025 (view filing)Nov 17-182 daysLewis JoelPresident and CEOSSale−22.5K$6.07−$136.4K−2.6%832.6K after2 lots10b5-1
Nov 19, 2025 (view filing)Nov 17-182 daysCallicutt Jack WChief Financial OfficerSSale−77.9K$6.14−$478.7K−91.1%7.61K after5 lots10b5-1
Nov 14, 2025 (view filing)Nov 131 dayJamil KhurramChief Medical OfficerSSale−104.9K$5.47−$573.6K−95.9%4.48K after3 lots10b5-1
Nov 14, 2025 (view filing)Nov 131 dayJamil KhurramChief Medical OfficerSSale−16.3K$5.47−$88.9K−78.4%4.48K after10b5-1
Nov 12, 2025 (view filing)4:33 PM ETNov 111 dayCzirr James C and 2 others10% OwnerSSale−40.0K$5.25−$210.0K−0.7%5.83M after
Nov 12, 2025 (view filing)Nov 102 daysLewis JoelPresident and CEOSSale−1.87K$6.03−$11.3K−0.2%832.6K after10b5-1
Nov 12, 2025 (view filing)Nov 102 daysCallicutt Jack WChief Financial OfficerSSale−5.29K$6.03−$31.9K−41.0%7.61K after3 lots10b5-1
Nov 7, 2025 (view filing)Nov 52 daysLewis JoelPresident and CEOSSale−200$6.00−$1.20K0.0%832.6K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysCallicutt Jack WChief Financial OfficerSSale−600$6.00−$3.60K−7.3%7.61K after3 lots10b5-1
Nov 5, 2025 (view filing)Nov 3-42 daysLewis JoelPresident and CEOSSale−15.7K$6.07−$95.3K−1.9%832.6K after2 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysCallicutt Jack WChief Financial OfficerSSale−2.56K$6.01−$15.4K−25.2%7.61K after2 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysCallicutt Jack WChief Financial OfficerSSaleCommno stock−1.25K$6.01−$7.51K−14.1%7.61K after10b5-1
Nov 5, 2025 (view filing)Nov 41 dayCallicutt Jack WChief Financial OfficerSSale−28.6K$6.07−$173.8K−79.0%7.61K after3 lots10b5-1
Oct 24, 2025 (view filing)8:18 PM ETOct 222 daysCzirr James C and 2 others10% OwnerSSale−50.0K$4.94−$246.8K−0.8%5.87M after2 lots
Sep 15, 2025 (view filing)Sep 123 daysCallicutt Jack WChief Financial OfficerSSale−8.71K$6.44−$56.1K−53.3%7.61K after10b5-1
Sep 15, 2025 (view filing)Sep 123 daysLewis JoelPresident and CEOSSale−14.0K$6.36−$89.0K−1.7%832.6K after10b5-1
Jul 22, 2025 (view filing)Jul 211 dayEldred KaryDirectorPPurchase+1.00K$2.93+$2.93K+1.6%64.7K after
Jul 18, 2025 (view filing)Jul 171 dayFreeman Kevin DDirectorPPurchase+5.00K$2.90+$14.5K+11.2%49.8K after
Dec 31, 2024 (view filing)Dec 301 dayShlevin Harold H.DirectorPPurchase+6.50K$1.16+$7.54K+74.7%15.2K after
Dec 26, 2024 (view filing)Dec 233 daysJamil KhurramChief Medical OfficerSSale−13.7K$0.88−$12.0K−34.1%26.3K after10b5-1
Dec 26, 2024 (view filing)Dec 233 daysLewis JoelPresident and CEOSSale−56.0K$0.89−$49.8K−5.9%897.0K after10b5-1
Dec 26, 2024 (view filing)Dec 233 daysCallicutt Jack WChief Financial OfficerSSale−40.0K$0.89−$35.6K−84.0%7.61K after10b5-1
Dec 26, 2024 (view filing)Dec 242 daysZordani Richard A. Jr.DirectorPPurchase+10.0K$0.82+$8.20K+31.2%42.1K after
Dec 26, 2024 (view filing)Dec 242 daysEldred KaryDirectorPPurchase+13.5K$0.82+$11.0K+26.8%63.7K after
Dec 26, 2024 (view filing)Dec 242 daysFreeman Kevin DDirectorPPurchase+10.0K$0.81+$8.10K+28.8%44.8K after
Oct 23, 2024 (view filing)Oct 23Same dayEldred KaryDirectorPPurchase+500$2.60+$1.30K+1.0%50.2K after
Oct 17, 2024 (view filing)Oct 17Same dayFreeman Kevin DDirectorPPurchase+1.30K$2.64+$3.43K+3.9%34.8K after
Oct 16, 2024 (view filing)Oct 16Same dayFreeman Kevin DDirectorPPurchase+5.00K$2.70+$13.5K+17.6%33.5K after